• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA¿ CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA¿ CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383517
Device Problem Split (2537)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/23/2018
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.Medical device expiration date: unknown. device manufacture date: unknown.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the extension tubing split in half on a bd nexiva¿ closed iv catheter system while performing an exam on a radiology patient.There was no report of exposure to mucous membranes, serious injury or medical intervention.
 
Event Description
"it was reported that the extension tubing split in half on a bd nexiva¿ closed iv catheter system while performing an exam on a radiology patient.There was no report of exposure to mucous membranes, serious injury or medical intervention.".
 
Manufacturer Narrative
Due to an it issue beginning on (b)(6) 2018, previously filed emdrs did not contain required fields.This supplemental emdr is filed to provide the following omitted fields: device returned to manufacture: yes.
 
Manufacturer Narrative
Investigation summary: dhr review - a review of the dhr could not be performed as no batch number was provided.Qn database review - a review of the qn database could not be performed as no batch number was provided.The cause of failure mode for tubing damage is indeterminate.Based on the customer¿s verbatim description, the effect of the device failure was leakage that did not require medical intervention.Rm5796 rev 16(o) nexiva p-eura identifies stations in the manufacturing process that can cause damage to the extension tubing resulting in leakage and states that the effect of minor leakage has a limited severity with ranking s2.The end user effect of minor leakage has occasional occurrence of o3 ( =100 ipm) for the failure mode of damaged extension tubing.The failure mode of components rupture outside the patient during power injection is identified as a failure mode in rm5769 rev 14(m) nexiva a-eura.For this failure mode, the end user effect of leakage that does not require medical intervention has a limited severity of s2 and occasional occurrence of o3 ( =100 ipm).With limited severity and occasional occurrence, the risk to the end user is acceptable.Occurrence rate of the defect for this batch could not be established as no batch information was provided.Sample analysis - the returned unit exhibits burst extension tubing.The customer's experience was confirmed.The defective unit did not display any evidence of damage due to the manufacturing process causing the extension tubing to burst.Root cause is indeterminate.Occlusion of the fluid pathway (e.G.Occluded catheter, kinked tubing, pinch clamp engaged during infusion) will increase the internal pressure of the unit and can cause the extension tubing to break, balloon, and/or burst.D16383 rev4(c) nexiva dual port instructions for use advises that measures should be taken to avoid kinking or obstructing the catheter system during power injection to avoid product failure.Burst or ballooning damage to the tubing can also occur if infusion is not performed correctly or performed at a psi/flow rate above the recommendations listed in d16383 rev4(c) nexiva dual port instructions for use.Severity is limited, and no manufacturing root cause was identified.A formal corrective action will not be initiated at this time.Customer complaint trends are evaluated on a monthly basis.If the trend of a specific type of complaint warrants a formal corrective action, resources will be assigned at that time.
 
Event Description
It was reported that the extension tubing split in half on a bd nexiva¿ closed iv catheter system while performing an exam on a radiology patient.There was no report of exposure to mucous membranes, serious injury or medical intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA¿ CLOSED IV CATHETER SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key7518901
MDR Text Key108624240
Report Number1710034-2018-00199
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903835172
UDI-Public30382903835172
Combination Product (y/n)N
PMA/PMN Number
K161777
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Type of Report Initial,Followup,Followup
Report Date 08/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/16/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number383517
Device Lot NumberUNKNOWN
Date Manufacturer Received04/23/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-